Drug Type Chemical drugs |
Synonyms |
Mechanism 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), 5-HT2B receptor antagonists(Serotonin 2b (5-HT2b) receptor antagonists), 5-HT2C receptor agonists(Serotonin 2c (5-HT2c) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | - | - | 05 Oct 2023 |
Psychotic Disorders | Preclinical | US | 05 Oct 2023 | |
Schizophrenia | Preclinical | US | 05 Oct 2023 |